Valuation: PolyPeptide Group AG

Market Cap 1.56B 1.76B 1.46B 1.33B 2.5B 169B 2.53B 17.62B 6.83B 86.29B 6.59B 6.45B 277B P/E 2026 *
49.7x
P/E 2027 * 29.9x
Enterprise Value 1.67B 1.88B 1.56B 1.42B 2.68B 181B 2.71B 18.89B 7.32B 92.48B 7.07B 6.91B 297B EV / Sales 2026 *
3.36x
EV / Sales 2027 * 2.97x
Free-Float
39.12%
Yield 2026 *
-
Yield 2027 * 0.14%
1 day+0.06%
1 week+0.11%
Current month+0.11%
1 month+0.34%
3 months-10.54%
6 months+48.40%
Current year+69.16%
1 week 44.05
Extreme 44.05
44.15
1 month 43.95
Extreme 43.95
44.25
Current year 23.1
Extreme 23.1
50.1
1 year 21.8
Extreme 21.8
50.1
3 years 13.22
Extreme 13.22
50.1
5 years 13.22
Extreme 13.22
146
10 years 13.22
Extreme 13.22
147.4
Manager TitleAgeSince
Chief Executive Officer 54 12/04/2023
Director of Finance/CFO 54 02/01/2024
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Director/Board Member 73 01/01/2006
Chairman 69 01/04/2021
Director/Board Member 62 01/01/2021
Date Insider Type Main position Quantity % Market Cap. Importance
13/11/23 Buy 2,500 0.0075%
12/10/23 Buy 159,959 0.4829%
06/04/23 Buy 45,842 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
+0.06%+0.11%+69.81%+157.89% 1.76B
-0.61%-3.43%+36.07%+115.04% 1,019B
-1.02%-5.60%+35.72%+64.63% 617B
+1.11%-0.58%+12.36%+77.95% 464B
+0.34%-3.01%+61.79%+41.24% 356B
+1.13%-1.46%+21.43%+41.95% 333B
+1.02%-3.05%+11.25%+34.93% 267B
+0.45%-4.51%-6.27%+9.41% 244B
-1.04%-2.79%+35.30%+51.84% 218B
-1.87%-4.10%+28.44%+93.66% 179B
Average +0.01%-3.19%+30.59%+68.85% 369.89B
Weighted average by Cap. -0.00%-3.54%+29.21%+70.81%

Financials

2026 *2027 *
Net sales 498M 560M 464M 423M 798M 53.83B 806M 5.62B 2.18B 27.52B 2.1B 2.06B 88.32B 574M 646M 535M 488M 920M 62.07B 929M 6.48B 2.51B 31.73B 2.42B 2.37B 102B
Net income 25M 28.14M 23.33M 21.27M 40.11M 2.7B 40.48M 282M 109M 1.38B 106M 103M 4.44B 45M 50.65M 42M 38.28M 72.2M 4.87B 72.87M 508M 197M 2.49B 190M 186M 7.99B
Net Debt 112M 126M 105M 95.28M 180M 12.12B 181M 1.27B 490M 6.19B 473M 463M 19.88B 146M 164M 136M 124M 234M 15.8B 236M 1.65B 639M 8.08B 617M 604M 25.92B
Logo PolyPeptide Group AG
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Employees
1,460
Date Price Change Volume
05/10/26 CHF 44.15 +0.11% 9,658
02/10/26 CHF 44.10 0.00% 36,888
01/10/26 CHF 44.10 0.00% 51,605
30/09/26 CHF 44.10 +0.11% 84,898
29/09/26 CHF 44.05 -0.11% 23,228
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
47.25EUR
Average target price
42.12EUR
Spread / Average Target
-10.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PPGN Stock